Research Institute: Centre for Cancer Biology
Amount granted: $3.5 million
Year granted: 2009
The Centre for Cancer Biology (CCB) was launched in 2009 and the new cancer genomics facility sought to maximise the unique expertise of the chief investigators and the local tissue bank resources.
The new cancer genome facility brought a new dimension to cancer research in Adelaide. It helped to obtain insights into the genetic modifications that underpin the development of new tools for better diagnostics, disease prognosis, drug response, and resistance to chemotherapy. Ultimately clinical translation is leading to a more personalised and effective cancer management.
Chief Investigators: Prof Angel Lopez, Sharad Kumar, Tim Hughes, Hamish Scott
What your donations have achieved
Cervical cancer vaccine
We gave initial seed funding to Professor Ian Frazer’s research into the cervical cancer (HPV). Over 150 million doses of vaccine have been delivered worldwide to date.
The pill that melts away cancer
Our long term support of cancer research at WEHI has led to a treatment that melts away certain advanced forms of chronic lymphocytic leukaemia. It has been approved for clinical use in the US, European Union and Australia and is being trialled for other types of cancer.
Personalised cancer diagnosis
In 2015, we awarded $10 million seed funding to an ambitious cancer proteome project that aims to provide each cancer patient a personalised treatment plan within 36 hours. This will improve treatment outcomes and help avoid unnecessary treatments.
Zero childhood cancer
We are one of the founding partners of the initiative that will tackle the most serious cases of infant, childhood and adolescent cancer in Australia. It is a key step towards the program vision of one day helping to cure 100% of children with cancer.